Nurse’s Role in Prevention and Management of Nail Toxicities in Women with Breast Cancer on Chemotherapy: A Case Study
Keywords:
chemotherapy, nail toxicities, nurse’s role, symptom management, women with breast cancerAbstract
Nail toxicities are induced by chemotherapy in women with breast cancer, which not only creates discomfort for patients but also results in suffering and pain, limiting the activities of daily life (ADL). This article aims to analyze the issues related to nail toxicities in women with breast cancer. The Symptom Management Model developed by Dodd et al. was applied, which includes three main concepts including: 1) symptom experience, 2) symptom management strategies and 3) outcome. The outcome of management was functioning status, which was measured using the National Cancer Institute Common Toxicity Criteria [NCI-CTC] version 3. The patient in the case study was level one. Therefore, nurses take a vital role in protecting and managing nail toxicities in women with breast cancer in order to reduce inflammation and increase satisfaction with their body image and nail cosmetics, as well as enable them to better perform ADL.
References
National Cancer Institute. Hospital-Based Cancer Registry 2019 [Internet]. 2020 [cited 2020Jan 8]. Available from: http://www.nci.go.th/th/File_download/Nci%20Cancer%20 Registry /Hospital-Based%202019%20NCI.pdf (in Thai)
Tiemsan T, Wacton P, Panyo S. Hematological toxicity in breast cancer patients undergoing chemotherapy at Phrae hospital. Cancer J 2019;39:121-32. (in Thai)
Jongkhetkit W, Promkaew P, Sumdangsan D. Gastrointestinal and fatigue symptom cluster management in patients with breast cancer receiving chemotherapy. Medical Journal of Srisaket Surin Buriram Hospitals 2019;34(2):217-31. (in Thai)
Peyton L, Fischer-Cartlidge E.Extremity Cooling: a synthesis of cryotherapy interventions to reduce peripheral neuropathy and nail changes from taxane-based chemotherapy. Clin J Oncol Nurs 2019;23(5):522-28. doi: 10.1188/19.CJON.522-528. PMID: 31538978.
Ferreira MN, Ramseier JY, Leventhal JS. Dermatologic conditions in women receiving systemic cancer therapy. Int J Womens Dermatol 2019;5(5):285-307. doi: 10.1016/j. ijwd.2019.10.003.
Dodd M, Janson S, Facione N, Faucett J, Froelicher ES, Humphreys J, et al.Advancing the science of symptom management.J Adv Nurs 2001;33(5):668-76.doi: 10.1046/j.1365-2648.2001.01697.x.
National Cancer Institute. Common terminology criteria for adverse events v3.0 (CTCAE) [Internet]. 2006 [cited 2021 Jan 8]. Available from https://ctep.cancer.gov/ protocoldevelopment/electronic_applications/docs/ctcaev3.pdf
Prajapati VB, Madhyastha S, Acharya R, Gopalaswamy V, Doddamani A. Cyclophos-phamide and doxorubicin induced melanonychia: a case report. J Clin Diagn Res 2017;11(1):OD04-OD05. doi: 10.7860/ JCDR/2017/23041.9216.
Sibaud V, Leboeuf NR, Roche H, Belum VR, Gladieff L, Deslandres M, et al. Dermatological adverse events with taxane chemotherapy. Eur J Dermatol 2016;26(5): 427-43. doi:10.1684/ejd.2016.2833
Subash VK, Radha S, Thatikonda S, Rao AY, Prakash CSK. Nail toxicity induced by cancer chemotherapy patients: data from the two multispecialty hospital. Res J Pharm Tech 2015;8(1):20-6. doi: 10.5958/0974-360X.2015.00004.9
Swenson KK, Bell EM, Nissen J. Nail toxicity associated with paclitaxel treatment for ovarian cancer. Oncol Nurs Forum 2013;40(1):17-9.
Alba BK, Castellani JW, Charkoudian N. Cold-induced cutaneous vasoconstriction in humans: function, dysfunction and the distinctly counterproductive.Exp Physiol 2019;104(8):1202-14. doi: 10.1113/EP087718
Can G, Aydiner A, Cavdar I. Taxane-induced nail changes: predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity. Euro J Oncol Nurs 2012;16(3):270-5. doi: 10.1016/j.ejon.2011.06.007
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Srisavarindhira Thai Red Cross Institute of Nursing
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
เนื้อหาบทความหรือข้อคิดเห็นต่างๆ ในวารสารพยาบาลสภากาชาดไทยนี้ เป็นความคิดเห็นของผู้เขียนบทความ ไม่ใช่ความเห็นของกองบรรณาธิการ หรือสถาบันการพยาบาลศรีสวรินทิรา สภากาชาดไทย
